Loading…

Pharmacophore-based small molecule CXCR4 ligands

SAR studies of low molecular weight CXCR4 ligands are reported. Low molecular weight CXCR4 ligands were developed based on the peptide T140, which has previously been identified as a potent CXCR4 antagonist. Some compounds with naphthyl, fluorobenzyl and pyridyl moieties as pharmacophore groups in t...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2012-06, Vol.22 (12), p.4169-4172
Main Authors: Narumi, Tetsuo, Tanaka, Tomohiro, Hashimoto, Chie, Nomura, Wataru, Aikawa, Haruo, Sohma, Akira, Itotani, Kyoko, Kawamata, Miyako, Murakami, Tsutomu, Yamamoto, Naoki, Tamamura, Hirokazu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SAR studies of low molecular weight CXCR4 ligands are reported. Low molecular weight CXCR4 ligands were developed based on the peptide T140, which has previously been identified as a potent CXCR4 antagonist. Some compounds with naphthyl, fluorobenzyl and pyridyl moieties as pharmacophore groups in the molecule showed significant CXCR4-binding activity and anti-HIV activity. Structure–activity relationships were studied and characteristics of each of these three moieties necessary for CXCR4 binding were defined. In this way, CXCR4 ligands with two types of recognition modes for CXCR4 have been found.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2012.04.032